@article{baf197931dde48ee869b1f7dc8a2aaf9,
title = "Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome",
abstract = "Teduglutide, a GLP-2 analogue, may restore intestinal structural and functional integrity by promoting repair and growth of the mucosa and reducing gastric emptying and secretion, thereby increasing fluid and nutrient absorption in patients with short bowel syndrome (SBS). This 24-week placebo-controlled study evaluated the ability of teduglutide to reduce parenteral support in patients with SBS with intestinal failure.",
keywords = "Adult, Aged, Algorithms, Body Composition, Body Weight, Combined Modality Therapy, Dose-Response Relationship, Drug, Female, Fluid Therapy, Gastrointestinal Agents, Humans, Male, Middle Aged, Parenteral Nutrition, Peptides, Short Bowel Syndrome, Treatment Outcome, Young Adult",
author = "Jeppesen, {P B} and R Gilroy and M Pertkiewicz and Allard, {J P} and B Messing and O'Keefe, {S J}",
year = "2011",
doi = "10.1136/gut.2010.218271",
language = "English",
volume = "60",
pages = "902--14",
journal = "Gut",
issn = "0017-5749",
publisher = "BMJ Publishing Group",
number = "7",
}